Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -8,583 | -5,970 | -7,170 | -11,300 |
| Depreciation Amortization | 624 | 420 | 380 | 1,300 |
| Accounts receivable | 274 | N/A | N/A | N/A |
| Other Working Capital | 188 | -490 | 30 | 4,430 |
| Other Operating Activity | -252 | -40 | 10 | 1,700 |
| Operating Cash Flow | $-7,749 | $-6,080 | $-6,750 | $-3,870 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -2,805 | N/A | N/A | N/A |
| PPE Investments | -239 | -180 | -80 | -680 |
| Purchase Sale Intangibles | -321 | N/A | N/A | N/A |
| Other Investing Activity | -321 | -910 | -6,780 | -1,080 |
| Investing Cash Flow | $-3,364 | $-1,090 | $-6,860 | $-1,760 |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | -58 | N/A | N/A | N/A |
| Common Stock Issued | 5,798 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 720 | 11,950 | -80 |
| Financing Cash Flow | $5,740 | $720 | $11,950 | $-80 |
| Exchange Rate Effect | -1 | -1 | 0 | -40 |
| Beginning Cash Position | 9,742 | 9,740 | 6,180 | 24,920 |
| End Cash Position | 3,721 | 3,280 | 4,530 | 19,150 |
| Net Cash Flow | $-6,021 | $-6,450 | $-1,650 | $-5,770 |
| Free Cash Flow | ||||
| Operating Cash Flow | -7,749 | -6,080 | -6,750 | -3,870 |
| Free Cash Flow | -7,749 | -6,080 | -6,750 | -3,870 |